Impact of direct-acting antiviral therapy for hepatitis C–related hepatocellular carcinoma

With the introduction of direct-acting antiviral (DAA) agents, hepatitis C virus (HCV) treatment has dramatically improved. However, there are insufficient data on the benefits of DAA therapy in hepatocellular carcinoma (HCC). The purpose of this study was to investigate the outcome of patients who...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:PLoS One
Egile Nagusiak: Lin, Wei-Chen, Lin, Yang-Sheng, Chang, Chen-Wang, Chang, Ching-Wei, Wang, Tsang-En, Wang, Horng-Yuan, Chen, Ming-Jen
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2020
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7244104/
https://ncbi.nlm.nih.gov/pubmed/32442193
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0233212
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak